Literature DB >> 25163592

Depression and cardiovascular disease: an update on how course of illness may influence risk.

Jess G Fiedorowicz1.   

Abstract

Depression constitutes a novel and independent risk factor for cardiovascular disease, which despite extensive support in the literature has been underappreciated. While much of the evidence for depression as a risk factor for cardiovascular disease is based on studies following myocardial infarction, the elevated vascular risk conveyed by depression is not confined to periods following acute coronary syndromes. For that matter, the risk appears across mood disorders with evidence for even greater risk in bipolar disorder. This review summarizes the literature linking depressive disorders to cardiovascular mortality with a focus on how the course of illness of mood disorders may influence this risk. Mood disorders may influence risk over decades of illness in a dose-response to symptom burden, or the persistence of affective symptomatology. This may be mediated through changes in the activity of the autonomic nervous system, the hypothalamic-pituitary-adrenal axis, and inflammatory cytokines. Whether treatment of depression can mitigate this risk is not established although there are suggestions to support this contention, which could be better studied with more effective treatments of depression and larger standardized samples. Directions for future study of mechanisms and treatment are discussed. Regardless of causal mechanisms, persons with depressive disorders and other risk factors for vascular disease represent a neglected, high-risk group for cardiovascular events. In addition to the appropriate treatment for depression, screening and optimized management of traditional risk factors for cardiovascular diseases is necessary.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25163592      PMCID: PMC4153989          DOI: 10.1007/s11920-014-0492-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  98 in total

1.  2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Philip Greenland; Joseph S Alpert; George A Beller; Emelia J Benjamin; Matthew J Budoff; Zahi A Fayad; Elyse Foster; Mark A Hlatky; John McB Hodgson; Frederick G Kushner; Michael S Lauer; Leslee J Shaw; Sidney C Smith; Allen J Taylor; William S Weintraub; Nanette K Wenger; Alice K Jacobs
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

2.  To include or not to include? A response to the meta-analysis of heart rate variability and depression.

Authors:  Carmilla M M Licht; Brenda W Penninx; Eco J C de Geus
Journal:  Biol Psychiatry       Date:  2011-02-15       Impact factor: 13.382

3.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

4.  The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample.

Authors:  Jess G Fiedorowicz; Jianping He; Kathleen R Merikangas
Journal:  J Psychosom Res       Date:  2010-09-18       Impact factor: 3.006

5.  Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.

Authors:  Karina W Davidson; Nina Rieckmann; Lynn Clemow; Joseph E Schwartz; Daichi Shimbo; Vivian Medina; Gabrielle Albanese; Ian Kronish; Mark Hegel; Matthew M Burg
Journal:  Arch Intern Med       Date:  2010-04-12

6.  Vascular function in older adults with depressive disorder.

Authors:  Raghupathy Paranthaman; Adam S Greenstein; Alistair S Burns; J Kennedy Cruickshank; Anthony M Heagerty; Alan Jackson; Rayaz A Malik; Marietta L J Scott; Robert C Baldwin
Journal:  Biol Psychiatry       Date:  2010-07-15       Impact factor: 13.382

7.  Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries.

Authors:  Adam S Greenstein; Raghupathy Paranthaman; Alistair Burns; Alan Jackson; Rayaz A Malik; Robert C Baldwin; Anthony M Heagerty
Journal:  Hypertension       Date:  2010-08-16       Impact factor: 10.190

Review 8.  Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis.

Authors:  Andrew H Kemp; Daniel S Quintana; Marcus A Gray; Kim L Felmingham; Kerri Brown; Justine M Gatt
Journal:  Biol Psychiatry       Date:  2010-02-06       Impact factor: 13.382

9.  Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males.

Authors:  Yi-Chyan Chen; Wei-Win Lin; Yu-Jung Chen; Wei-Chung Mao; Yi-Jen Hung
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

10.  Anger, depression and anxiety associated with endothelial function in childhood and adolescence.

Authors:  W Osika; S M Montgomery; F Dangardt; P Währborg; L M Gan; E Tideman; P Friberg
Journal:  Arch Dis Child       Date:  2009-10-11       Impact factor: 3.791

View more
  34 in total

Review 1.  Perspectives on the Management of Vascular Depression.

Authors:  Warren D Taylor; Susan K Schultz; Vanessa Panaite; David C Steffens
Journal:  Am J Psychiatry       Date:  2018-12-01       Impact factor: 18.112

2.  Bipolar disorder and related mood states are not associated with endothelial function of small arteries in adults without heart disease.

Authors:  Brian Tong; Oluchi Abosi; Samantha Schmitz; Janie Myers; Gary L Pierce; Jess G Fiedorowicz
Journal:  Gen Hosp Psychiatry       Date:  2017-12-19       Impact factor: 3.238

3.  Evidence for cardiotoxicity associated with sertraline in rats.

Authors:  Sinem Ilgin; Volkan Kilic; Merve Baysal; Gozde Aydogan-Kilic; Seyda Ucarcan; Begum Dermenci; Ozlem Atli
Journal:  Toxicol Res (Camb)       Date:  2018-04-06       Impact factor: 3.524

Review 4.  Mental and Addictive Disorders and Medical Comorbidities.

Authors:  Elizabeth Reisinger Walker; Benjamin G Druss
Journal:  Curr Psychiatry Rep       Date:  2018-08-28       Impact factor: 5.285

5.  A Multilevel Analysis of Patient Engagement and Patient-Reported Outcomes in Primary Care Practices of Accountable Care Organizations.

Authors:  Stephen M Shortell; Bing Ying Poon; Patricia P Ramsay; Hector P Rodriguez; Susan L Ivey; Thomas Huber; Jeremy Rich; Tom Summerfelt
Journal:  J Gen Intern Med       Date:  2017-02-03       Impact factor: 5.128

6.  The development of depressive symptoms during medical internship stress predicts worsening vascular function.

Authors:  Jess G Fiedorowicz; Vicki L Ellingrod; Mariana J Kaplan; Srijan Sen
Journal:  J Psychosom Res       Date:  2015-06-18       Impact factor: 3.006

7.  Quantifying between-cohort and between-sex genetic heterogeneity in major depressive disorder.

Authors:  Maciej Trzaskowski; Divya Mehta; Wouter J Peyrot; David Hawkes; Daniel Davies; David M Howard; Kathryn E Kemper; Julia Sidorenko; Robert Maier; Stephan Ripke; Manuel Mattheisen; Bernhard T Baune; Hans J Grabe; Andrew C Heath; Lisa Jones; Ian Jones; Pamela A F Madden; Andrew M McIntosh; Gerome Breen; Cathryn M Lewis; Anders D Børglum; Patrick F Sullivan; Nicholas G Martin; Kenneth S Kendler; Douglas F Levinson; Naomi R Wray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-01       Impact factor: 3.568

Review 8.  Positive emotion and cardiovascular disease in elderly people.

Authors:  Lina Ma; Yun Li; Ming Feng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

9.  Peripheral inflammation during abnormal mood states in bipolar I disorder.

Authors:  Jess G Fiedorowicz; Alan R Prossin; Casey P Johnson; Gary E Christensen; Vincent A Magnotta; John A Wemmie
Journal:  J Affect Disord       Date:  2015-08-21       Impact factor: 4.839

10.  Changes in inflammation with treatment for bipolar II depression: Pilot trial data on differential effects of psychotherapy and medication.

Authors:  Jess G Fiedorowicz; Jill M Cyranowski; Zhuangzhuang Liu; Holly A Swartz
Journal:  Neurol Psychiatry Brain Res       Date:  2019-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.